Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We outline a transfection protocol for producing chimeric antigen receptor-natural killer (CAR-NK) cells targeting fungal pathogens using the non-viral Sleeping Beauty transposon system. To assess antigen-specific activation, we co-cultured the engineered cells with Aspergillus fumigatus germ tubes and measured IFN-γ secretion.

Abstract

Chimeric antigen receptor (CAR)-based cell therapies have shown impressive efficacy in the treatment of hematological malignancies. Recently, these therapies are being developed for infectious diseases, yet studies targeting fungal infections remain scarce. To identify optimal targets and optimize cellular products, we developed a method to engineer chimeric antigen receptor-natural killer (CAR-NK) cells and evaluated their response to stimulation by fungi. This paper describes a straightforward and robust method for generating CAR-NK cells tailored to fungal targets using the non-viral Sleeping Beauty transposon system. NK-92 cells are transfected with the hyperactive transposase SB100X vectorized as minicircle DNA (MC) along with a plasmid-encoded CAR transposon. Transfection efficiency is assessed 1 week later using flow cytometric analysis. Prior to functional testing, the cells expressing the transgene are enriched using magnetic-activated cell sorting and cultured for 1 more week. To evaluate antigen-specific activation, the engineered cells are co-cultured with Aspergillus fumigatus germ tubes for at least 6 h. Subsequently, the concentration of the secreted interferon-gamma (IFN-γ) is measured using an enzyme-linked immunosorbent assay.

Introduction

Aspergillus fumigatus (A. fumigatus) is a ubiquitous fungus, with the average person inhaling between 100 and 1,000 conidia on a daily basis1. In patients with acquired or congenital immunodeficiencies, such as those undergoing chemotherapy or who are suffering from leukemia, A. fumigatus can result in severe invasive apsergillosis. Each year, more than 200,000 people worldwide contract aspergillosis. Despite the use of antimycotics for prevention and therapy with azole derivatives, the mortality rate remains between 30% and 95%2,3. Additionally, the treatment....

Protocol

All experiments described here must be conducted under sterile conditions. In this protocol, we show two conditions: (I) Mock transfection without DNA that will serve as control and (II) CAR transfection using the previously described Af-CAR6. The Af-CAR plasmid contains a truncated epidermal growth factor receptor (EGFRt) sequence downstream of the CAR, which will be used as a transfection marker (Supplemental Figure S1). For each condition, 4 × 106 NK-92 cells ar.......

Representative Results

The entire process of generating Af-CAR NK-92 cells, including transfection, recovery, enrichment, and expansion, takes approximately 14 days. After transfection, the cells are cultured and split every second day. Cell viability may decrease during the first splitting two days post transfection. Typically, the cells recover 4 days post transfection and begin proliferating, with a doubling time of 48 h.

Following recovery, transfection efficiencies are measured and are expected to reach 10-20% .......

Discussion

The provided protocol offers a simple and reliable method for creating CAR-NK cells that target fungal pathogens using the non-viral Sleeping Beauty transposon system. This method allows for the stable and permanent insertion of large transgenes, which enables the expansion of cells to obtain the necessary quantities for further analysis14,16.

Several key factors can impact the success of the transfection, including cell number and via.......

Acknowledgements

Funding and support for the project were provided by Wilhelm Sander Stiftung, project 2020.017.1 to M.H., and J.L.; Deutsche Forschungsgemeinschaft (Collaborative Research Center/Transregio 124 Pathogenic fungi and their human host: Networks of interaction-FungiNet; project A8 to M.H. and H.E.).

....

Materials

NameCompanyCatalog NumberComments
15 ML conical bottom tubesGreiner Bio-One188271PP, 17/120 MM, CELLSTAR, STERILE
50 ML conical bottom tubesGreiner Bio-One227270PP, 30/115 MM, CELLSTAR, STERILE
6-and 96-Well- Cell culture plateCorning Inc. LifeSciences83-3736/ 83-3474TC-treated Multiple Well Plates, Flat bottoms, Treated for optimal cell attachment, Sterilized by gamma irradiation, Nonpyrogenic
7-AAD (7-Aminoactinomycin D)BD Biosciences559925eady-to-use nucleic acid dye for the exclusion of nonviable cells in flow cytometric assays
Alexa Fluor 647 anti-human EGFR AntibodyBiolegend352918Clone AY13
Anti-Biotin MicroBeads UltraPureMiltenyi Biotec130-105-637UltraPure MicroBeads conjugated to monoclonal mouse anti-biotin antibodies
Aspergillus fumigatusATCC46645
Biosphere Filter Tips (20 and 100 μL) Sarstedt70.3030.365 / 70.3030.275
Dulbecco′s Phosphate Buffered Saline (PBS)Sigma-AldrichD8537 Modified, without calcium chloride and magnesium chloride, liquid, sterile-filtered, suitable for cell culture, endotoxin, tested
ELISA MAX Deluxe Set Human IFN-γBiolegend430104
Ethylenediaminetetraacetic acid disodium salt solution (EDTA)Sigma-AldrichE7889for molecular biology, 0.5 M in H2O, DNase, RNase, NICKase and protease, none detected, 0.2 μm filtered.
FACS cleanBD Biosciences340345
FACS Flow Sheath FluidBD Biosciences342003
FACS Rinse SolutionBD Bioscience340346
Fetal Bovine Serum (FBS)Sigma-AldrichF7524sterile-filtered, suitable for cell culture, heat inactivated before use
Gibco, MEM α, nucleosidesThermofisher Scientific22571020Phenol Red, Ribonucleosides, Deoxyribonucleosides, Sodium Bicarbonate
Horse serumThermo Fisher Scientific16050122Sterile-filtered, heat inactivated before use
Human IL-2 IS, research gradeMiltenyi Biotec130-097-742Research grade. The ED50 is ≤0.3 ng/mL, corresponding to an activity of ≥3 × 106 IU/mg.
IonomycinSigma-AldrichI0634-1MGfrom Streptomyces conglobatus, used as positive control for cytokine secretion 
L-GlutamineSigma-AldrichW368401For cell culture
MACS LS ColumnMiltenyi Biotec130-042-401 Columns and plungers, sterile packed
NK-92DSMZACC 488
Neon Transfektionssystem 100 μL-KitThermo Fisher ScientificMPK10096Resuspension Buffer R, Electrolytic Buffer E2, 100 μL Neon Tips, Neon Electroporation Tubes
Phorbol-12-myristat-13-acetat (PMA)Sigma-AldrichP1585-1MGused as positive control for cytokine secretion 
Polystyrene round-bottom tube, 5 mLBD BioscienceS-452400used for flow cytometry
Reaction tube, 1.5 MLGreiner Bio-One7,26,90,001PP, transparent, cap attached, with injected graduation. Sterilized before use. 
RPMI 1640 Medium, GlutaMAXThermo Fisher Scientific72400021GlutaMax I,  Phenol Red, HEPES, Sterile-filtered
TipOne 1000 μL XL Graduated Filter TipStarLabS1122-1730
Equipment
BD FACSCaliburBD Bioscience
CO2 Incubator C60 Labotect
Heraeus Multifuge 3SRThermo Scientific
HydroFLEX microplate washer Tecan
NanoQuant Infinite M200 ProTecan
Neon Transfection SystemInvitrogen
Pipettes Eppendorf
Quadro MACS Separator Miltenyi Biotec

References

  1. Fang, W., Latgé, J. -. P. Microbe profile: Aspergillus fumigatus: A saprotrophic and opportunistic fungal pathogen. Microbiology (Reading). 164 (8), 1009-1011 (2018).
  2. Brown, G. D., et al. Hidden killers: Human fungal in....

Explore More Articles

Immunology and InfectionNK 92 cellsAspergillus fumigatusCARTransfectionSleeping Beauty transposon system

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved